Results of ACTIV-3 trial published: Experimental monoclonal antibody not efficacious in Phase 3 trial
Preliminary results of a phase 3, randomized, placebo-controlled clinical trial testing the investigative monoclonal antibody LY-CoV555 in hospitalized COVID-19 patients …